SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-23-002381
Filing Date
2023-04-19
Accepted
2023-04-18 20:21:47
Documents
6
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_041823.htm DEF 14A 781641
2 GRAPHIC logo.jpg GRAPHIC 6809
3 GRAPHIC compactual.jpg GRAPHIC 51982
4 GRAPHIC comploss.jpg GRAPHIC 53719
5 GRAPHIC pcards_01.jpg GRAPHIC 364766
6 GRAPHIC pcards_02.jpg GRAPHIC 322205
  Complete submission text file 0001171843-23-002381.txt   1883568
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32001 | Film No.: 23828277
SIC: 2836 Biological Products, (No Diagnostic Substances)